ArticleScientific reports2026
Socio-demographic and clinical determinants of dyslipidaemia in hypertensive patients at the Effia Nkwanta Hospital; a cross-sectional study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dyslipidaemia and hypertension are significant independent risk factors for cardiovascular disease, and the two mostly exist together in clinical cases. This study aimed to determine the socio-demographic and clinical determinants of dyslipidaemia among hypertensive patients attending Effia Nkwanta Regional Hospital. A cross-sectional study was conducted among 347 adults with clinically diagnosed hypertension. Sociodemographic, lifestyle, anthropometric, and clinical data were collected using a structured questionnaire. Fasting serum lipid profiles were assessed using enzymatic methods. Dyslipidaemia was defined using standard lipid reference ranges. Data were analysed using SPSS version 26.0. Overall, 58.5% of participants had dyslipidaemia, with 52.7% being female. The residence of participants (p = 0.04), income (p = 0.008), history of smoking (p = 0.04), BMI (p = 0.02) and waist-hip ratio (p = 0.02) were significantly associated with dyslipidaemia status. The most common symptoms among all patients were early morning headaches and irregular heart rhythms. There was no significant difference in the prevalence of early morning headaches (p = 0.72) and irregular rhythms (p = 0.76) between participants with dyslipidemia and those without. Obese (OR = 0.432, p = 0.004) and overweight (OR = 0.401, p = 0.001) participants were less likely to have dyslipidaemia. Significant associations were also observed between occupation and triglyceride levels (p = 0.02) and LDL levels (p = 0.008). Dyslipidaemia is highly prevalent among hypertensive patients and is influenced by socio-demographic and clinical factors. Routine lipid screening and integrated cardiovascular risk management should be prioritized in the care of individuals with hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.